| Susanne G Defedele, PCNS | |
|
101 Higginson Ave, Suite 107 D, Lincoln, RI 02865-2732 | |
| (401) 723-7007 | |
| Not Available |
| Full Name | Susanne G Defedele |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent |
| Location | 101 Higginson Ave, Lincoln, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952484545 | NPI | - | NPPES |
| 411680 | Other | RI | BLUE CHIP OF RI |
| 27266-5 | Other | RI | BCBS OF RI |
| SD51376 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0807X | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent | PPNS00002 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susanne G Defedele, PCNS 101 Higginson Ave, Suite 107 D, Lincoln, RI 02865-2732 Ph: (401) 723-7007 | Susanne G Defedele, PCNS 101 Higginson Ave, Suite 107 D, Lincoln, RI 02865-2732 Ph: (401) 723-7007 |
News Archive
A new review by David A. Walsh and Joanne Stocks in the September 2017 issue of SLAS Discovery (formerly the Journal of Biomolecular Screening) explores evolving treatments and future therapies for osteoarthritis (OA) pain.
Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, and The University of Manchester have entered into an agreement with AstraZeneca to establish a clinical pharmacology biomarker research and discovery collaboration.
Nine months into the COVID-19 pandemic, scientists are still seeking to understand the protective immunity that develops against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the increasing need for serological tests in epidemiology, their clinical value has not been fully established. A new paper published in the Journal of Medical Virology in September 2020 describes the relationship of COVID-19 disease symptoms with the serological status over time.
In one of the most extensive studies, researchers have found the connection between different types of food and types of stroke risk. The study titled, "The associations of major foods and fiber with risks of ischaemic and hemorrhagic stroke: a prospective study of 418,329 participants in the EPIC cohort across nine European countries," was published in the latest issue of the journal European Heart Journal today.
GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal.
› Verified 8 days ago
Susan Gelfer Ginsberg, PCNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 8 Blackstone Valley Pl, 2nd Floor, Lincoln, RI 02865 Phone: 401-334-1830 |